These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Coronavirus as a possible cause of severe acute respiratory syndrome. Peiris JS; Lai ST; Poon LL; Guan Y; Yam LY; Lim W; Nicholls J; Yee WK; Yan WW; Cheung MT; Cheng VC; Chan KH; Tsang DN; Yung RW; Ng TK; Yuen KY; Lancet; 2003 Apr; 361(9366):1319-25. PubMed ID: 12711465 [TBL] [Abstract][Full Text] [Related]
43. Late recognition of SARS in nosocomial outbreak, Toronto. Wong T; Wallington T; McDonald LC; Abbas Z; Christian M; Low DE; Gravel D; Ofner M; Mederski B; Berger L; Hansen L; Harrison C; King A; Yaffe B; Tam T Emerg Infect Dis; 2005 Feb; 11(2):322-5. PubMed ID: 15752456 [TBL] [Abstract][Full Text] [Related]
45. Automated extraction protocol for quantification of SARS-coronavirus RNA in serum: an evaluation study. Chiu RW; Jin Y; Chung GT; Lui WB; Chan AT; Lim W; Lo YM BMC Infect Dis; 2006 Feb; 6():20. PubMed ID: 16466582 [TBL] [Abstract][Full Text] [Related]
46. [Isolation and identification of the infective agent of severe acute respiratory syndrome (SARS) from a patient with atypical pneumonia]. Onishchenko GG; Vasil'ev NT; Maksimov VA; Markov VI; Merkulov VA; Pistsov MN; Berezhnoĭ AM; Syromiatnikova SI; Zubov VV Zh Mikrobiol Epidemiol Immunobiol; 2003; (5):109-12. PubMed ID: 14565137 [TBL] [Abstract][Full Text] [Related]
47. [What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019]. Liu YJ; Yang YL; Xu Y Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):339-344. PubMed ID: 32294817 [TBL] [Abstract][Full Text] [Related]
48. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Hsu LY; Lee CC; Green JA; Ang B; Paton NI; Lee L; Villacian JS; Lim PL; Earnest A; Leo YS Emerg Infect Dis; 2003 Jun; 9(6):713-7. PubMed ID: 12781012 [TBL] [Abstract][Full Text] [Related]
49. Co-circulation of human metapneumovirus and SARS-associated coronavirus during a major nosocomial SARS outbreak in Hong Kong. Lee N; Chan PK; Yu IT; Tsoi KK; Lui G; Sung JJ; Cockram CS J Clin Virol; 2007 Dec; 40(4):333-7. PubMed ID: 17936066 [TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome. Yang Z; Xu M; Yi JQ; Jia WD Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):60-3. PubMed ID: 15730921 [TBL] [Abstract][Full Text] [Related]
51. Severe acute respiratory syndrome (SARS) in children. Wong GW; Fok TF Pediatr Pulmonol Suppl; 2004; 26(Suppl 26):69-71. PubMed ID: 15029602 [No Abstract] [Full Text] [Related]
52. Infectious diseases. One year after outbreak, SARS virus yields some secrets. Enserink M Science; 2004 May; 304(5674):1097. PubMed ID: 15155925 [No Abstract] [Full Text] [Related]
53. Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Zhu H; Hu S; Jona G; Zhu X; Kreiswirth N; Willey BM; Mazzulli T; Liu G; Song Q; Chen P; Cameron M; Tyler A; Wang J; Wen J; Chen W; Compton S; Snyder M Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4011-6. PubMed ID: 16537477 [TBL] [Abstract][Full Text] [Related]
54. [Clinical presentation and management of the severe acute respiratory syndrome (SARS)]. Rickerts V; Wolf T; Rottmann C; Preiser W; Drosten C; Jakobi V; Leong HN; Brodt HR Dtsch Med Wochenschr; 2003 May; 128(20):1109-14. PubMed ID: 12748900 [TBL] [Abstract][Full Text] [Related]
55. Early diagnosis of SARS: lessons from the Toronto SARS outbreak. Muller MP; Richardson SE; McGeer A; Dresser L; Raboud J; Mazzulli T; Loeb M; Louie M; Eur J Clin Microbiol Infect Dis; 2006 Apr; 25(4):230-7. PubMed ID: 16586072 [TBL] [Abstract][Full Text] [Related]
56. Molecular diagnosis of severe acute respiratory syndrome. Ng EK; Lo YM Methods Mol Biol; 2006; 336():163-75. PubMed ID: 16916262 [TBL] [Abstract][Full Text] [Related]
57. Broad-spectrum coronavirus antiviral drug discovery. Totura AL; Bavari S Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247 [TBL] [Abstract][Full Text] [Related]
58. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. Drosten C; Chiu LL; Panning M; Leong HN; Preiser W; Tam JS; Günther S; Kramme S; Emmerich P; Ng WL; Schmitz H; Koay ES J Clin Microbiol; 2004 May; 42(5):2043-7. PubMed ID: 15131168 [TBL] [Abstract][Full Text] [Related]
60. Detection of SARS coronavirus in humans and animals by conventional and quantitative (real time) reverse transcription polymerase chain reactions. Peiris JS; Poon LL Methods Mol Biol; 2008; 454():61-72. PubMed ID: 19057863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]